Biosurgery products are used in various surgeries to minimize the intra and post-operative complications. Various synthetic and biologic products like anti-adhesive agents, hemostatic agents, surgical sealing agents, bone graft substitutes, and soft tissue management are utilized in surgeries for preventing excessive blood loss or providing adhesion or wound/tissue sealing, and repair of damaged or weakened tissues or bones of a body. These advanced products enhance the work efficiency of physicians by controlling surgery-related difficulties in expensive and complicated surgeries.
The size of global biosurgery market is expected to increase substantially in the near future, owing to high investment, increasing R&D spending, aggressive strategies adopted by top players such as new product launches. Other factors that drive the growth of the biosurgery market are technological advancements (high efficiency products, multi-usage products and plasma based products), availability of multifunctional products, rising number of surgeries owing to the increasing rate of obesity and other lifestyle-related diseases, and increasing sports-related injuries. However, the high cost associated with surgeries, stern regulatory environment for product approval and growing popularity of minimally invasive surgeries are likely to restrict its growth in various regions.
The world biosurgery market was evaluated at $6,912.2 million in 2014, and is estimated to garner $12,758.1 million by 2022, registering a CAGR of 8.1% over the forecast period. The report segments the biosurgery market on the basis of product type, application, source, and geography. On the basis of product type, the market is segmented into anti-adhesive agents, hemostatic agents, surgical sealants, bone graft substitutes, and soft tissue management (mesh/patch). According to application, it is classified into cardiovascular and thoracic, neuro and spine, orthopedic, general, and others surgeries. Others surgery covers urological, gynecological, rhytidectomy, and reconstructive surgeries. Based on the source, it is segmented into natural and synthetic products. Geographic breakdown and a deep analysis of each of the aforesaid segments is included for North America, Europe, Asia-Pacific, and LAMEA.
High investment from top players and increasing R&D spending on multi-usage products (such as fibrin sealants) are likely to provide ample opportunities to the industry players across regions. Recently in 2015, the U.S. FDA approved Infuse bone graft implantation from Medtronic PLC, which is made up of polyetheretherketone compound, for oblique lateral interbody fusion and anterior lumbar interbody fusion. Furthermore, in March 2015, Kuros Biosurgery received a U.S. patent for its synthetic hydrogel technology. It is a combination of bioactivebiomaterial products such as sealant and orthobiologics. A comprehensive competitive analysis and profiles of major industry players such as Johnson & Johnson (Ethicon), Baxter International, Medtronic PLC, Stryker, Atrium Medical (Maquet Getinge Group), C. R. Bard, CryoLife Inc., Haemostasis LLC, Kuros Bioscience, and Sanofi are also provided in this report.
KEY BENEFITS FOR STAKEHOLDERS:
BIOSURGERY MARKET KEY SEGMENTS:
By Product Type
SIMILAR MARKET STUDIES
The number of people taking dental care treatment is increasing year by year, which was 21.971 million in 2012, grew by 9.24%. On average, one dentist treats 7.4 people per day. By the end of 2012, there were 344 professional dental hospitals in China, grew by 8.52%. Compared with increasing ...
July 2015 | $3500 | View Details >>
The China Dental Software Management Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Dental Software Management industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Dental Software Management market analysis is provided ...
April 2016 | $3200 | View Details >>
Market Research Report on Global and Chinese Fulvestrant Industry, 2009-2019 is a professional and in-depth market survey on Global and Chinese Fulvestrant industry. The report firstly reviews the basic information of Fulvestrant including its classification, application and manufacturing technology; The report then explores global and China’s top manufacturers of Fulvestrant ...
September 2014 | $2400 | View Details >>
Disposable Sterile Acupuncture Needles has its origin from China. It involves the insertions of thin needles into certain locations of the human body. These locations are generally termed as acupuncture points and form the main focus of the acupuncture treatment. The procedure may also involve the application of pressure, heat ...
November 2016 | $3480 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research